| Date Filed | Type | Description |
| 07/21/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2023 |
4
| RA CAPITAL MANAGEMENT, L.P. (10% Owner) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 06/16/2023 |
4
| Lichter Jay (10% Owner) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 06/16/2023 |
4
| McNulty Alana B. (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 06/16/2023 |
4
| Simson Jake (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 06/16/2023 |
4
| Kung Winston (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 06/16/2023 |
4
| Gujrathi Sheila (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 06/16/2023 |
4
| CAPPS VICKIE L (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 06/16/2023 |
4
| Barrett Ronald W (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $13.22, valued at
$165.3k
|
|
| 01/05/2023 |
4
| Winter Charles M. (Chief Technical Officer) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $14.02, valued at
$1.4M
|
|
| 01/05/2023 |
4
| Robinson Byron (Chief Strategy Officer) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 100,000 options to buy
@ $14.02, valued at
$1.4M
|
|
| 01/05/2023 |
4
| Reardon Tighe (Acting CFO) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 110,000 options to buy
@ $14.02, valued at
$1.5M
|
|
| 01/05/2023 |
4
| Meyer Andrew Hollman (Chief Business Officer) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 90,000 options to buy
@ $14.02, valued at
$1.3M
|
|
| 01/05/2023 |
4
| Godfrey Wayne (Chief Medical Officer) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 110,000 options to buy
@ $14.02, valued at
$1.5M
|
|
| 01/05/2023 |
4
| Campbell David Alan (CEO) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 310,000 options to buy
@ $14.02, valued at
$4.3M
|
|
| 01/05/2023 |
3
| Winter Charles M. (Chief Technical Officer) has filed a Form 3 on Janux Therapeutics, Inc. |
| 09/22/2022 |
4
| Kung Winston (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 30,000 options to buy
@ $13.54, valued at
$406.2k
Granted 9,375 options to buy
@ $13.54, valued at
$126.9k
|
|
| 09/22/2022 |
3
| Kung Winston (Director) has filed a Form 3 on Janux Therapeutics, Inc. |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| McNulty Alana B. (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $10.73, valued at
$134.1k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Heller Stefan (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $10.73, valued at
$134.1k
|
|
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2022 |
4
| Simson Jake (Director) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 12,500 options to buy
@ $10.73, valued at
$134.1k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 01/05/2022 |
4
| Salek-Ardakani Shahram (Chief Scientific Officer) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 114,250 options to buy
@ $20.24, valued at
$2.3M
|
|
| 01/05/2022 |
4
| Reardon Tighe (Acting CFO) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 116,750 options to buy
@ $20.24, valued at
$2.4M
|
|
| 01/05/2022 |
4
| Meyer Andrew Hollman (Chief Business Officer) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 106,750 options to buy
@ $20.24, valued at
$2.2M
|
|
| 01/05/2022 |
4
| Godfrey Wayne (Chief Medical Officer) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 114,250 options to buy
@ $20.24, valued at
$2.3M
|
|
| 01/05/2022 |
4
| Campbell David Alan (CEO) has filed a Form 4 on Janux Therapeutics, Inc.|
Txns:
| Granted 354,250 options to buy
@ $20.24, valued at
$7.2M
|
|
|